Myomar Molecular
PrivateLast Round
Seed
May 11, 2026
Total Funding Raised
$4.51M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Myomar Molecular is a biotechnology company that is developing a panel of blood tests to detect and monitor muscle loss (atrophy).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myomar Molecular Comparables
Compare Myomar Molecular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyoCorps | 78% | |
| Biobytes | 69% | |
| InsideTracker | 54% | |
Myomar Molecular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 11, 2026 | ||||
| Grant | May 11, 2026 | ||||
| Pre Seed | Mar 1, 2024 | ||||
| Convertible Debt | Feb 7, 2023 |
Myomar Molecular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northern Ontario Angels | Seed |
| Government of Canada | Pre Seed |
| Women's Equity Lab | Pre Seed |
| Government of Nova Scotia | Pre Seed |
| Northern Ontario Heritage Fund Corporation | Grant |
| Ontario Centre of Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 4, representing 33% of headcount.
- Jul 26, 2026
Grew 40% QoQ from 10 to 14 employees.
Myomar Molecular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Myomar Molecular's valuation, stock price, and market status.